NEW YORK (

TheStreet

) --

Harbor BioSciences

(HRBR)

shares tumbled during Monday's trading session after the company announced a $2.06 million equity financing deal.

Harbor BioSciences

said it has entered into an agreement with certain institutional investors to raise approximately $2.06 million in gross proceeds through the sale of approximately 5.9 million shares of its common stock and warrants to purchase approximately 3.5 million shares.

Harbor BioSciences said the shares of common stock and warrants will be sold in units, with each unit consisting of one share of common stock and a warrant to purchase 0.6 of a share of common stock. The purchase price per unit is 35 cents, compared to the closing price Friday of 43 cents a share.

Shares of Harbor BioSciences slid 6.4% to 40 cents at the shortly after Monday's opening bell.

Elsewhere,

Bon-Ton Stores

(BONT)

filed late Friday for a $150 million mixed securities shelf offering. Bon-Ton said any net proceeds will be used for general corporate purposes, including capital expenditures, repayment or refinancing of borrowings, working capital, investments and acquisitions.

Bon-Ton

shares were lately up 0.9% to $11.13.

TST Recommends

Lin TV

(TVL)

also filed late Friday for a $225 million mixed securities shelf offering, with any net proceeds to be used to for general corporate purposes. That may include reducing or refinancing indebtedness, financing possible acquisitions and redeeming outstanding securities, Lin TV said. Shares were up 1% to $6.31.

Meanwhile,

CoreLogic

(CLGX) - Get Report

filed for a $400 million common stock shelf offering, which includes selling shareholders. CoreLogic said any net proceeds from securities it offers will be used for general corporate purposes, although it will not receive any of the proceeds from the sale of shares of common stock by the selling stockholders.

CoreLogic shares were lately down 2.1% to $19.72.

Grubb & Ellis

( GBE) filed for a 16.04 million share common stock offering by selling shareholders. Grubb & Ellis said it will not receive any proceeds from such sales. Shares were trading flat at $1.30.

-- Written by Robert Holmes in Boston

.

Follow Robert Holmes on

Twitter

and become a fan of TheStreet.com on

Facebook.